Kendall Capital Management Regeneron Pharmaceuticals, Inc. Transaction History

Kendall Capital Management

$316 Million
Q3 2024

A detailed history of Kendall Capital Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kendall Capital Management holds 2,347 shares of REGN stock, worth $1.68 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

2,347

Previous 2,417 2.9%

Holding current value

$1.68 Million

Previous $2.54 Million 2.87%

% of portfolio

0.78%

Previous 0.87%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1024.09 - $1201.76 $71,686 - $84,123	-70 Reduced 2.9%	2,347 $2.47 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $61,824 - $74,983	-70 Reduced 2.81%	2,417 $2.54 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $189,564 - $208,603	-210 Reduced 7.79%	2,487 $2.39 Million
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $58,138 - $66,127	-75 Reduced 2.71%	2,697 $2.37 Million
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $175,189 - $213,625	-253 Reduced 8.36%	2,772 $2.28 Million
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $38,501 - $45,669	-55 Reduced 1.79%	3,025 $2.17 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $389,240 - $473,026	572 Added 22.81%	3,080 $2.53 Million
Q4 2022 Jan 30, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 0.4%	2,508 $1.81 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $5,165 - $6,518	-9 Reduced 0.36%	2,518 $1.74 Million
Q2 2022 Jul 29, 2022	BUY	$548.35 - $738.84 $128,313 - $172,888	234 Added 10.2%	2,527 $1.49 Million
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $5,951 - $6,984	10 Added 0.44%	2,293 $1.6 Million
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $39,130 - $48,309	-72 Reduced 3.06%	2,283 $1.44 Million
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $24,683 - $29,281	-43 Reduced 1.79%	2,355 $1.43 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $54,501 - $66,880	122 Added 5.36%	2,398 $1.14 Million
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $52,613 - $66,877	110 Added 5.08%	2,276 $1.1 Million
Q3 2020 Oct 22, 2020	SELL	$544.75 - $658.21 $40,856 - $49,365	-75 Reduced 3.35%	2,166 $1.21 Million
Q2 2020 Jul 30, 2020	SELL	$493.32 - $643.92 $34,532 - $45,074	-70 Reduced 3.03%	2,241 $1.4 Million
Q1 2020 Apr 27, 2020	SELL	$336.18 - $494.43 $55,469 - $81,580	-165 Reduced 6.66%	2,311 $1.13 Million
Q4 2019 Jan 24, 2020	BUY	$274.13 - $376.51 $132,404 - $181,854	483 Added 24.23%	2,476 $930,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $68,365 - $79,597	250 Added 14.34%	1,993 $553,000
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $124,034 - $171,735	414 Added 31.15%	1,743 $546,000
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $175,249 - $207,037	471 Added 54.9%	1,329 $546,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $63,469 - $76,174	189 Added 28.25%	858 $320,000
Q3 2018 Oct 29, 2018	BUY	$351.14 - $408.51 $234,912 - $273,293	669 New	669 $270,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Regeneron Pharmaceuticals, Inc. Transaction History